Table 3.
Positive symptoms | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
P1 | P2 | P3 | P4 | P5 | ||||||
Predictor | R2N | β | R2N | β | R2N | β | R2N | β | R2N | β |
.050* | .024 | .02 | 06** | .04 | ||||||
Age | −.13** | .03 | −.02 | .02 | −.04 | |||||
Education | .21** | .03 | .10 | −.12* | 11 | |||||
Sex | .10 | −.18 | −.10 | −.56** | 31 | |||||
BLAP | −.24 | −.51 | −.10 | −.06 | .37 | |||||
BLAD | .33 | .10 | .16 | .13 | .09 | |||||
BLST | .49 | −.05 | −.23 | −.97* | −.41 | |||||
BLMS | .04 | .03 | .69 | .07 | −1.17* | |||||
n | 356 | 356 | 356 | 356 | 356 |
Note. P1 = unusual thought content; P2 = suspiciousness; P3 = grandiosity; P4 = perceptual abnormalities; P5 = disorganized communication. β = unstandardized coefficient; BLAP = baseline antipsychotic use; BLAD = baseline antidepressant use; BLST = baseline stimulant use; BLMS = baseline mood stabilizer use.
p < .05.
p < .01.